Picture of Jubilant Pharmova logo

JUBLPHARMA — Jubilant Pharmova News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

India's Jubilant Pharmova hits 3-year high as unit announces investment in French firm

** Shares of Jubilant Pharmova  JUBA.NS  climb ~5% to 899
rupees, their highest since May 2021
    ** Drugmaker's subsidiary issues "put option offer" to
Pierre Fabre Laboratories to acquire 80% stake in a new company
for 4.4 mln euros ($5 mln) to be incorporated in France
    **Says, new co will buy Pierre Fabre's R&D centre
    ** Pierre Fabre will hire services from co's Jubilant Biosys
unit up to 7 mln euros for first four years
    ** JUBA up ~65% YTD vs ~46% last year
    
($1 = 0.9054 euros)

 (Reporting by Kashish Tandon in Bengaluru)
 ((kashish.tandon@thomsonreuters.com))

Recent news on Jubilant Pharmova

See all news